PubMed ID:
20400194
Public Release Type:
Journal
Publication Year: 2010
Affiliation: Université Catholique de Louvain, Cliniques universitaires St Luc, Bruxelles, Belgium. etienne.sokal@uclouvain.be
DOI:
https://doi.org/10.1016/j.jhep.2010.01.028
Authors:
Bourgois A,
Fischler B,
Gardovska D,
Kelly D,
Porta G,
Silveira T,
Sokal EM,
Stéphenne X
Studies:
Pegylated Interferon +/- Ribavirin for Children with HCV
This multi-center study aimed to prospectively evaluate the safety and efficacy of a genotype-based Pegylated Interferon alfa-2a/Ribavirin therapy in treatment-naïve hepatitis C virus (HCV), positive HCV serology, and quantifiable HCV RNA, infected children.